Urine24 is expanding its international network through a carefully selected group of exclusive country partners.
Who Can Become a Partner?
We welcome organizations with experience in healthcare and laboratory diagnostics, including
Clinical laboratories
Expand your diagnostic portfolio with a standardized bladder cancer screening program supported by advanced cytology, molecular diagnostics, and digital pathology.
Diagnostic centers
Deliver preventive healthcare services to patients and referring physicians an innovative, integrated screening solution through a turnkey implementation model.
Hospital groups
Strengthen your oncology and pathology services by implementing a comprehensive bladder cancer screening workflow across your healthcare network.
Public health
Support population health initiatives with a standardized screening model designed to improve early detection and facilitate coordinated care.
orOther qualified healthcare operators
We collaborate with qualified healthcare organizations, clinical laboratories, diagnostic providers, and medical institutions that want to introduce an innovative urine screening program in their local market.
Proven in Italy. Ready for the World.
Your Country.
Your Exclusive Urine24 Center
After successfully implementing the Urine24 screening model in Italy, we are now expanding internationally through exclusive country partnerships. Join us in bringing a new standard for bladder cancer screening to your healthcare system.
Each approved partner is granted exclusivity within an agreed geographical territory, allowing them to develop the Urine24 program with confidence and long-term strategic value. This exclusive model encourages investment, protects market development, and supports sustainable growth.
Each approved partner is granted exclusivity within an agreed geographical territory, allowing them to develop the Urine24 program with confidence and long-term strategic value. This exclusive model encourages investment, protects market development, and supports sustainable growth.
Why Partner with Urine24?
Our goal is to deliver everything needed to build a sustainable, scalable, and internationally standardized bladder cancer screening program.
A Complete Bladder Cancer Screening EcosystemUrine24 for Large-Scale Screening Programs
Urine24 is the first integrated bladder cancer screening ecosystem designed to support early detection through a standardized, scalable, and technology-driven workflow. Rather than offering a single diagnostic product, Urine24 combines proprietary technologies, laboratory expertise, digital pathology, and molecular diagnostics into one comprehensive solution.
Dedicated urine preservation chemistry
Developed to maintain optimal sample integrity from collection through laboratory processing.
Hospitex Liquid-Based Cytology (LBC)
The world's only liquid-based cytology system specifically optimized for urine samples.
Automated scanning and digital pathology
Enabling standardized image acquisition, remote review, and workflow optimization.
Integrated FISH confirmation
Validate suspicious or positive cytology findings, supporting greater diagnostic confidence.
High-sensitivity FISH probes
Specifically selected and developed probes for bladder cancer detection.
A secure digital platform
Case management, workflow monitoring, reporting, and data integration.
Lead the Future of Bladder Cancer Screening
A Scalable and Sustainable
Healthcare Opportunity
The Urine24 Partner Program is built around a centralized laboratory model designed to deliver high-quality bladder cancer screening services on a national scale.
Each Exclusive Country Partner establishes a dedicated Urine24 reference laboratory, supported by a complete implementation package that includes laboratory design, technology integration, training, software, consumables, and ongoing technical assistance.
Each Exclusive Country Partner establishes a dedicated Urine24 reference laboratory, supported by a complete implementation package that includes laboratory design, technology integration, training, software, consumables, and ongoing technical assistance.
Initial Laboratory Setup
A fully operational Urine24 Central Laboratory typically requires an initial investment of approximately €1 million, depending on local infrastructure, regulatory requirements, and laboratory capacity.
Integrated pay-per-test Service
The service covers all laboratory consumables, full access to the Urine24 digital platform for case management and reporting, together with ongoing software updates and technical support, ensuring a standardized and efficient workflow for every examination.
Market Potential
On average, approximately 20% of a country's population falls within the primary target group for bladder cancer screening.
This provides partners with the opportunity to develop a large-scale, sustainable screening program tailored to their local healthcare system.
This provides partners with the opportunity to develop a large-scale, sustainable screening program tailored to their local healthcare system.
A Long-Term Partnership
The Urine24 business model combines recurring diagnostic activity with continuous access to proprietary consumables, software, scientific support, and technology updates, creating a sustainable long-term partnership between Urine24 and its exclusive country partners.
A Proven Implementation ProcessOur partnership follows a structured implementation pathway:
Every phase is supported by the Urine24 team to ensure successful deployment. Urine24 offers a comprehensive implementation program designed to help partners establish a fully operational bladder cancer screening service quickly, efficiently, and according to standardized international protocols.
From the initial planning phase through to the launch of the laboratory, our team provides a complete implementation roadmap, including clinical and operational procedures, laboratory workflow design, and support for equipment selection and system integration. Partners also gain access to our proprietary software platform, dedicated digital tools, and all the consumables required to deliver the Urine24 screening workflow.
To ensure long-term success, we provide comprehensive training for laboratory personnel and clinical staff, together with marketing resources, scientific guidance, and ongoing technical assistance. Continuous software enhancements, product updates, and access to our latest innovations ensure that every partner remains aligned with the evolving Urine24 ecosystem.
From the initial planning phase through to the launch of the laboratory, our team provides a complete implementation roadmap, including clinical and operational procedures, laboratory workflow design, and support for equipment selection and system integration. Partners also gain access to our proprietary software platform, dedicated digital tools, and all the consumables required to deliver the Urine24 screening workflow.
To ensure long-term success, we provide comprehensive training for laboratory personnel and clinical staff, together with marketing resources, scientific guidance, and ongoing technical assistance. Continuous software enhancements, product updates, and access to our latest innovations ensure that every partner remains aligned with the evolving Urine24 ecosystem.
Initial evaluation
Assess your organization's capabilities and strategic fit.
Territory assessment
Evaluate market potential and exclusive
territory eligibility.
territory eligibility.
Partnership agreement
Define roles, responsibilities, and exclusive partnership terms.
Project planning
Develop a tailored implementation
roadmap and timeline.
roadmap and timeline.
Laboratory implementation
Set up the complete Urine24 laboratory ecosystem and validate it.
Staff training
Train laboratory and clinical teams on all workflows for excellence.
Apply to Become a Partner
Contact our international business development team to learn more about the qualification process and partnership requirements.
Call us
Laboratory Secretariat:
+39 345 7466065
Customer Service:
+39 055 062 2114
+39 345 7466065
Customer Service:
+39 055 062 2114
